Загрузка...
Why Do Immunosuppressed Patients with Inflammatory Bowel Disease Not Seem to Be at a Higher Risk of COVID-19?
The COVID-19 pandemic has created a public health emergency. In this context, there are major concerns for patients with inflammatory bowel disease (IBD), particularly for those treated with immunomodulators, biologics, and Janus Kinase inhibitors. Infection susceptibility is, in fact, one of the re...
Сохранить в:
| Опубликовано в: : | Dig Dis Sci |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer US
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7569008/ https://ncbi.nlm.nih.gov/pubmed/33073335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-020-06624-5 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|